Endo Int'l (ENDP) Announces Statistically Significant Data from Xiaflex Phase 2 in Dupuytren's Disease Nodules
Tweet Send to a Friend
Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (Nasdaq: ENDP), announced new data to be presented evaluating the safety ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE